Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,713,225
-$2,076,875 QoQ
Shares Held
27,607
-21.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#315
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2022CallValue
$0
CallShares
0
PutValue
$8,354,954
PutShares
32,015
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $233,247,691 across 19 Biotechnology names. VRTX ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
181,706 | $113,300,959 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,238,830 | $43,842,193 | |
| 3 | EXEL |
Exelixis, Inc.
|
419,730 | $22,837,509 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
73,879 | $13,836,059 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
27,607 | $13,713,225 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
133,805 | $10,906,445 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
68,548 | $5,435,170 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,130 | $2,447,373 |
All Filings in VRTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,713,225 | 27,607 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $15,790,100 | 35,361 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $44,393,011 | 97,920 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,779,733 | 86,252 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,085,926 | 49,609 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,423,696 | 27,688 | Shares | Defined | 2025-07-02 | |
| 2024-12-31 | $18,965,961 | 47,097 | Shares | Sole | 2025-07-02 | |
| 2024-09-30 | $34,727,523 | 74,670 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $24,076,739 | 51,367 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $94,443,505 | 225,936 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,368,369 | 62,347 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $20,503,791 | 58,963 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,805,139 | 25,021 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $7,357,197 | 23,351 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $12,321,664 | 42,668 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,765,025 | 33,726 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $18,324,239 | 65,028 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $11,346,452 | 43,478 | Shares | Defined | 2022-05-09 | |
| 2022-03-31 | $8,354,954 | 32,015 | Put | Defined | 2022-05-09 | |
| 2021-12-31 | $22,236,475 | 101,259 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $88,601,576 | 488,459 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,251,102 | 40,922 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $10,865,697 | 50,564 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $28,370,489 | 120,041 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $25,496,827 | 93,697 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $120,940,242 | 416,590 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $86,367,283 | 362,964 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||